| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/17/2011 | CN101879240B Chinese medicinal compound suppository for treating endometritis of livestock and preparation method thereof |
| 08/17/2011 | CN101836953B Ambroxol hydrochloride composition injection |
| 08/17/2011 | CN101780094B Slow-release preparation of cucurbitacin |
| 08/17/2011 | CN101780089B Irbesartan hydrochlorothiazide capsule and preparation method thereof |
| 08/17/2011 | CN101732452B Cleaning tablet of oral cavity and preparation method thereof |
| 08/17/2011 | CN101732248B Metoprolol tartrate injection and preparation method thereof |
| 08/17/2011 | CN101703753B Medicinal composition powders or granules for treating whitevein and preparation method thereof |
| 08/17/2011 | CN101700254B Chinese medicine prescription granule flavoring agent, and preparation method and use method thereof |
| 08/17/2011 | CN101664464B Method for preparing granules for clearing heat and removing dampness |
| 08/17/2011 | CN101647789B Levetiracetam slow release pellet capsule preparation |
| 08/17/2011 | CN101642576B Polyethylene glycol-modified product of KGF-2 and preparation method thereof |
| 08/17/2011 | CN101642572B Protective freezedrying powder of marine microorganism neuzyme and preparation method |
| 08/17/2011 | CN101632665B Novel torasemide oral medicine composition |
| 08/17/2011 | CN101596166B Aspirin enteric-coated pellet |
| 08/17/2011 | CN101579309B Anti-parasitic ivermectin transdermal solution used for livestock and preparation method thereof |
| 08/17/2011 | CN101511367B Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 08/17/2011 | CN101507712B Sustained-release micro-spheres preparation containing recombined erythropoietin |
| 08/17/2011 | CN101455655B Creatine sustained-release preparation and preparation process thereof medication |
| 08/17/2011 | CN101439083B Detection method of Chinese medicine soft capsules for clearing wind heat and clearing nasal passage |
| 08/17/2011 | CN101420931B Solid preparation for oral application |
| 08/17/2011 | CN101406460B Euthyrox tablet |
| 08/17/2011 | CN101406458B Biodegradable polyester medicine-carrying microsphere of mimetic peroxidase |
| 08/17/2011 | CN101375869B Slow/controlled release pellet composition containing ginkgo leaf extracts and preparation method thereof |
| 08/17/2011 | CN101190232B Magnesium isoglycyrrhizinate freeze dried powder injection for injection and preparation method thereof |
| 08/17/2011 | CN101006992B Propofol freeze-dried emulsion and its preparing method |
| 08/17/2011 | CN101002772B Nanometer particle targeted preparation of hydroxycamptothecine, and its preparing method |
| 08/16/2011 | US7999073 Expression vector comprising nucleotide sequences coding nucleoprotein filaments for improving heterologous gene expression in cells |
| 08/16/2011 | US7999011 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 08/16/2011 | US7998929 A G-CSF solution formulation which is substantially free from proteins as a stabilizer but which contains at least one amino acid or a salt thereof as a stabilizer. |
| 08/16/2011 | US7998927 For reducing aggregation or immunogenicity of peptide or polypeptide including an alkylglycoside, especially dodecyl maltoside, tridecyl maltoside, sucrose monododecanoate, sucrose monotridecanoate, or sucrose monotetradecanoate; treatment of obesity |
| 08/16/2011 | US7998923 quantum dots surface attached with a bioactivation peptide having surface recognition part that is bound to the surface of such particle and and one or more functional parts attached to amino-end or a carboxy-end of molecular recognition part; hydrophobic spacer and binding clustures; bioconjugation |
| 08/16/2011 | US7998922 Process for treating fibroses with biocompatible polymer |
| 08/16/2011 | US7998590 Adhesive material |
| 08/16/2011 | US7998506 Dosing a hyperlipidemic with an effective anticholesterol amount of nicotinic acid once per day in the evening or at night; combined with a pharmaceutically acceptable carrier to form an oral solid dosage form; side effect reduction |
| 08/16/2011 | US7998503 Form of administration for controlling primary headaches |
| 08/16/2011 | US7998502 Encapsulated vaccines for the oral vaccination and boostering of fish and other animals |
| 08/16/2011 | US7998501 Newborn infant formulas and feeding methods |
| 08/16/2011 | US7998500 Nutritional supplement for women |
| 08/16/2011 | US7998492 Methods and products related to treatment and prevention of hepatitis C virus infection |
| 08/16/2011 | US7998105 Method of treating coronary arteries with perivascular delivery of therapeutic agents |
| 08/16/2011 | CA2493041C Injectable pharmaceutical composition for treating post-operative joint pain comprising an amide local anesthetic |
| 08/16/2011 | CA2472880C Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours |
| 08/16/2011 | CA2449002C Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin |
| 08/16/2011 | CA2446659C Agent for improving tissue penetration |
| 08/16/2011 | CA2405530C Film forming compositions containing sucralose |
| 08/16/2011 | CA2386960C Method for preparing a composition by mother-of-pearl extraction, comprising the mother-of-pearl integral components, composition obtained by said method and it's use in cosmetic and dermatology |
| 08/16/2011 | CA2376164C Intermolecularly associating compounds, and aggregates comprising them |
| 08/16/2011 | CA2321837C Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 08/16/2011 | CA2174928C Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 08/11/2011 | WO2011097633A2 Egf receptor mimicking peptides |
| 08/11/2011 | WO2011097384A2 Tumor targeted delivery of immunomodulators by nanoplymers |
| 08/11/2011 | WO2011097149A2 Taxane-and taxoid-protein compositions |
| 08/11/2011 | WO2011097138A1 Molecular entities for binding, stabilization and cellular delivery of negatively charged molecules |
| 08/11/2011 | WO2011096953A1 Oral antidepressant formulation with reduced excipient load |
| 08/11/2011 | WO2011096558A1 Easy-disintegrating polymeric micelle composition |
| 08/11/2011 | WO2011096513A1 Eye drops |
| 08/11/2011 | WO2011096230A1 Magnetic particles, process for producing same, and medicinal preparation including magnetic particles |
| 08/11/2011 | WO2011095938A1 Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use |
| 08/11/2011 | WO2011095814A1 Treatment of respiratory disorders |
| 08/11/2011 | WO2011095801A2 Pharmaceutical composition |
| 08/11/2011 | WO2011095661A1 Magnetic nanoparticles for use in a pharmaceutical composition |
| 08/11/2011 | WO2011095621A1 A method for altering the flavor of a food product |
| 08/11/2011 | WO2011095604A1 Half-life prolongation of proteins |
| 08/11/2011 | WO2011095543A1 Immunoglobulin preparation |
| 08/11/2011 | WO2011095449A1 Method for solubilizing hydrophobic active ingredients in an aqueous solution |
| 08/11/2011 | WO2011095311A1 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis |
| 08/11/2011 | WO2011094982A1 Solid formulation of clopidogrel bisulfate and preparation method thereof |
| 08/11/2011 | WO2011094822A1 Carrier composition |
| 08/11/2011 | WO2011094814A1 Carrier comprising non-neutralised tocopheryl phosphate |
| 08/11/2011 | WO2011073995A3 Liquid vaginal spray of progesterone |
| 08/11/2011 | WO2011072627A3 Dendritic high-molecular-weight polymer drug carriers and their conjugates with drugs especially for treatment of solid tumours |
| 08/11/2011 | WO2011069475A3 A method of preparation of an oxidized derivative of hyaluronic acid and a method of modification thereof |
| 08/11/2011 | WO2011031849A3 Anionic lipids and lipid nanostructures and methods of producing and using same |
| 08/11/2011 | WO2011008823A9 Peptide-mediated non-covalent delivery of active agents across the blood brain barrier |
| 08/11/2011 | WO2010134829A3 Nanocapsules intended for transferring toxic drugs to the sites of invasive diseases occurrence in a patient body and method of their preparation |
| 08/11/2011 | WO2010104563A3 Highly compactable and durable direct compression excipients and excipient systems |
| 08/11/2011 | WO2010091822A8 N-hydroxylated amidine-, guanidine- and/or aminohydrazone-type prodrugs for application on the skin |
| 08/11/2011 | US20110196474 Magnetically sensitive drug carriers for treatment or targeted delivery |
| 08/11/2011 | US20110196046 Pigments |
| 08/11/2011 | US20110195944 Modified release emulsions for application to skin or vaginal mucosa |
| 08/11/2011 | US20110195915 Method of inhibiting prostate cancer cell proliferation |
| 08/11/2011 | US20110195913 Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer |
| 08/11/2011 | US20110195907 Amino acid and peptide conjugates of amiloride and methods of use thereof |
| 08/11/2011 | US20110195901 Artery- and vein-specific proteins and uses therefor |
| 08/11/2011 | US20110195844 Process for solubilizing hydrophobic active ingredients in aqueous medium |
| 08/11/2011 | US20110195456 Methods and compositions for the production of monoclonal antibodies |
| 08/11/2011 | US20110195156 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
| 08/11/2011 | US20110195130 Edible compositions |
| 08/11/2011 | US20110195120 Sustained Release Pharmaceutical Composition Containing Metformin Hydrochloride |
| 08/11/2011 | US20110195114 Transdermal delivery systems for active agents |
| 08/11/2011 | US20110195101 Polysaccharide Capsules and Methods of Preparation |
| 08/11/2011 | US20110195089 Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens |
| 08/11/2011 | US20110195080 Compositions and Methods for Enhanced Somatostatin Immunogenicity in the Treatment of Growth Hormone and Insulin-Like Growth Factor One Deficiency |
| 08/11/2011 | US20110195040 Method for preventing the formation of adhesions following surgery or injury |
| 08/11/2011 | US20110195035 Ester Compounds For Use In Personal Care Products |
| 08/11/2011 | US20110195030 Nanoparticle compositions comprising liquid oil cores |
| 08/11/2011 | US20110195019 Nucleic acids and corresponding proteins entitled 251p5g2 useful in treatment and detection of cancer |
| 08/11/2011 | US20110192493 Liquid Pharmaceutical Formulations of Palonosetron |
| 08/11/2011 | CA2789144A1 Compositions and methods for treating obesity and obesity-related conditions |
| 08/11/2011 | CA2788863A1 Immunoglobulin preparation |